Health Benefits and Cost-effectiveness of a Hybrid Screening Strategy for Colorectal Cancer Tuan Dinh, Uri Ladabaum, Peter Alperin, Cindy Caldwell, Robert Smith, Theodore R. Levin Clinical Gastroenterology and Hepatology Volume 11, Issue 9, Pages 1158-1166 (September 2013) DOI: 10.1016/j.cgh.2013.03.013 Copyright © 2013 AGA Institute Terms and Conditions
Figure 1 Discounted QALYs and costs per person in the base case. The slope between strategies represents the ICER. A strategy that lies to the right and bottom of another strategy is dominant (more effective, less costly) over that strategy. Clinical Gastroenterology and Hepatology 2013 11, 1158-1166DOI: (10.1016/j.cgh.2013.03.013) Copyright © 2013 AGA Institute Terms and Conditions